Status
Terminated
Drug Enforcement D-0130-2023
CGMP Deviations: Raw material recalled by repackager, due to discoloration.
Classification
Class II
Report Date
January 11, 2023
Termination Date
May 4, 2023
Product Information
- Product description
- Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded by Pine Pharmaceuticals, 355 Riverwalk Pkwy, Tonawanda, NY 14150. NDC 69194-0948-1
- Product quantity
- 11,453 vials
- Reason for recall
- CGMP Deviations: Raw material recalled by repackager, due to discoloration.
- Recall initiation reason
- —
- Initial firm notification
- Distribution pattern
- Nationwide to medical facilities.
Location & Firm
- Recalling firm
- Pine Pharmaceuticals, LLC
- Address
-
355 Riverwalk Pkwy, N/A
United States - Voluntary / Mandated
- Voluntary: Firm initiated
- Status date
- —
Codes & Dates
- Recall number
- D-0130-2023
- Event ID
- 91378
- Recall initiation date
- December 22, 2022
- Center classification date
- January 13, 2023
- Code info
- Lot # 62881, Exp 12/25/2022; 62923, Exp 12/26/2022; 63066, Exp 01/03/2023; 63067, Exp 01/01/2023; 63103, Exp 01/02/2023; 63120, Exp 01/03/2023; 63219, 63226, Exp 01/08/2023; 63263, Exp 01/09/2023; 63380, 63381, Exp 01/15/2023; 63433, Exp 01/16/2023; 63455, Exp 01/17/2023; 63537, Exp 01/22/2023; 63580, Exp 01/23/2023; 63721, Exp 01/29/2023; 63792, Exp 01/31/2023; 63888, Exp 02/05/2023; 63930, Exp 02/06/2023; 63959, Exp 02/07/2023; 64079, Exp 02/13/2023; 64109, Exp 02/14/2023; 64239, Exp 02/21/2023.
- More code info
- —